Effect of Intravenous S-ketamine on Opioid Consumption

NACompletedINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

July 7, 2024

Study Completion Date

July 7, 2024

Conditions
Breast Cancer Surgery
Interventions
DRUG

S-ketamine (low dose)

Patients in the low-dose ketamine group will receive a bolus of 0.5 mg/kg S-ketamine in saline, followed by continuous infusion of 2 μg/kg/min S-ketamine in saline until 30 min prior to the end of the surgery.

DRUG

Placebo

Patients in the placebo group will receive a bolus of 0.9% saline, followed by continuous infusion of 0.9% saline until 30 min prior to the end of the surgery.

DRUG

S-ketamine (high dose)

Patients in the high-dose ketamine group will receive a bolus of 0.5 mg/kg S-ketamine in saline, followed by continuous infusion of 4 μg/kg/min S-ketamine in saline until 30 min prior to the end of the surgery.

Trial Locations (1)

230601

Second Affiliated Hospital of Anhui Medical University, Hefei

All Listed Sponsors
lead

The Second Hospital of Anhui Medical University

OTHER

NCT05060068 - Effect of Intravenous S-ketamine on Opioid Consumption | Biotech Hunter | Biotech Hunter